HK Stock Market Move | ADICON HOLDINGS (09860) rose nearly 7% during trading. The company recently reached a strategic cooperation agreement with the Clinical Testing Center of the Capital Medical University.

ADICON HOLDINGS (09860) rose nearly 7% during trading, reaching a 4.01% increase at the time of publication, at HKD 7.26 with a trading volume of HKD 1004.67 million. On the news front, in January of this year, the Clinical Testing Center of Capital Medical University reached a strategic cooperation with ADICON, where both sides will explore the development needs of precision medical testing and pathological diagnosis, as well as the cooperation model of medical-industrial-university research, to promote the transformation of innovative diagnostic technologies and their clinical applications, and to improve the quality of medical services. It is reported that ADICON HOLDINGS is one of the three largest independent clinical laboratories (ICL) in China. Huachuang Securities previously pointed out that the domestic ICL market penetration rate still lags behind foreign countries, but with the promotion of hierarchical diagnosis and treatment, the increasing pressure of medical insurance cost control, the reform of DRG/DIP payment methods, and the promotion of primary medical care construction, the domestic ICL industry is expected to enter a period of rapid development.